SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Tom Johnson8/8/2005 9:54:30 AM
   of 14101
 
If you go here clinicaltrials.gov and enter Dimethaid you will bring up the current info on the final Phase 3 Pennsaid study. The study began in Feb.04 and according to this site the final follow up will be completed in Sept. 05.
As well, the FDA has publicly stated that the average length for a Phase 3 study from beginning to acceptance/rejection is approx. 16 months. So allowing for recruitment etc. Sept. would appear to fit the time frame nicely.
Based on the above, Pennsaid should be getting an approval before too long (unless something completely unforseen was discovered). Am I missing something here?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News